PARP-1/Proteasome-IN-1 (compound 42i) is a dual inhibitor of PARP-1 and the proteasome, demonstrating significant inhibitory effects on breast cancer. By downregulating the expression of BRCA1 and RAD51, it impairs homologous recombination repair and induces apoptosis (cellular death).
Formula:
C36H46BFN4O5S
Target:
PARP|||Proteasome|||Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted